Condition 1: Disorders of mineral metabolism. Condition 2: Vitamin D deficiency. Condition 3: Chronic kidney disease. Condition 4: Abnormal levels of other serum enzymes. Disorders of mineral metabolism Vitamin D deficiency Chronic kidney disease Abnormal levels of other serum enzymes
Conditions
Interventions
Intervention 1: Intervention group: Patients in intervention groupwill be divided into three groups based on serum levels of 25-hydroxy vitamin D (mild deficient: 16 – 20 ng/Ml , moderate deficient: 1
Treatment - Drugs
Intervention group: Patients in intervention groupwill be divided into three groups based on serum levels of 25-hydroxy vitamin D (mild deficient: 16 – 20 ng/Ml , moderate deficient: 10 - 15 ng/Ml an
Control group: Patients in control group will be divided into three groups based on serum levels of 25-hydroxy vitamin D (mild deficient: 16 – 20 ng/Ml , moderate deficient: 10 - 15 ng/Ml and severe
Sponsors
Vice chancellor for research, Ardabil University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with chronic kidney disease; Exclusion criteria: patients with Multiple myeloma
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of 25(OH) vit D. Timepoint: At the beginning of study and 3 month after intervention. Method of measurement: Lab. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum levels of PTH. Timepoint: At the beginning of study and 3 month after intervention. Method of measurement: Lab.;Calcium serum level. Timepoint: At the beginning of study and 3 month after intervention. Method of measurement: Lab.;ALP serum level. Timepoint: At the beginning of study a 3 month after intervention. Method of measurement: Lab. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Zeinab Izadi
Ardabil University of Medical Sciences
Outcome results
None listed